Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES THE PRAMERICA GROUP IN CONNECTION WITH THE SALE OF ERIKSBERG SHOPPING CENTRE
Mandate

VINGE ADVISES THE PRAMERICA GROUP IN CONNECTION WITH THE SALE OF ERIKSBERG SHOPPING CENTRE

March 17, 2014

Vinge has advised TMW Pramerica Property Investment GmbH in connection with the sale of Fastighets AB Fogsvansen which owns and manages Eriksberg shopping centre in Gothenburg. The property is situated close to Linholmen in Hissingen and has a lettable area of 10 700 m2, all of which is currently leased to large tenants such AS Coop Extra and Systembolaget.

TMW Pramerica Immobilien GmbH is the European arm of Pramerica Real Estate Investors. The subsidiary, TMW Pramerica Property Investment GmbH acquired Eriksberg shopping centre in January 2005 on behalf of its fund, EuRetail. The Pramerica Group has owned the property for a decade.

Vinge’s team consisted of partner Magnus Pauli together with, among others, associates Mercedes Anderås, Natalie Bäck, Patrik Gargolinski, Lisa Hanicke, Daniel Lennartsson, Thelma Fredin and Frida Matsson as well as project assistant, Josefin Halldén. Partner Fredrik Vinge advised on financing issues and associate Maria Paijkull on environmental issues in relation to the transaction

Related

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

 Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

 Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024